MedMira Inc. (TSXV:MIR)
0.0700
0.00 (0.00%)
Jun 30, 2026, 10:53 AM EST
MedMira Market Cap
MedMira has a market cap or net worth of CAD 49.12 million as of July 1, 2026. Its market cap has decreased by -17.65% in one year.
Market Cap
49.12M
Enterprise Value
66.54M
Revenue
370.57K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since June 30, 2000, MedMira's market cap has decreased from 81.66M to 49.12M, a decrease of -39.85%. That is a compound annual growth rate of -1.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 49.12M | 7.69% |
| Dec 31, 2025 | 45.61M | -31.58% |
| Dec 31, 2024 | 66.66M | -13.11% |
| Dec 29, 2023 | 76.72M | 37.50% |
| Dec 30, 2022 | 55.80M | -60.00% |
| Dec 31, 2021 | 139.49M | -13.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eastwood Bio-Medical Canada | 68.89M |
| Telescope Innovations | 60.60M |
| ME Therapeutics Holdings | 59.80M |
| Sernova Biotherapeutics | 50.98M |
| NurExone Biologic | 50.63M |
| Microbix Biosystems | 41.33M |
| BriaCell Therapeutics | 38.45M |
| Medicenna Therapeutics | 36.00M |